Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies... Research Beam Model: Research Beam Product ID: 1702107 125 USD New
Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review
 
 

Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review

  • Category : Pharmaceuticals
  • Published On : July   2017
  • Pages : 32
  • Publisher : GlobalData
 
 
 
Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amarillo Biosciences Inc (ABI) is a specialty biopharmaceutical company, which focuses on the development of biologics for the treatment of human and animal diseases. It develops innovative therapeutic candidates for the treatment of human disease indications such as influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha. Its product portfolio includes a dietary supplement product, Maxisal to treat dryness of mouth. The company utilizes injectable interferon, an FDA-approved technology to develop drugs for the treatment of neoplastic, viral and autoimmune diseases. It has development partners in China and Taiwan and Nepal. ABI is headquartered in Amarillo, Texas, the US.

Amarillo Biosciences Inc Key Recent Developments

Oct 06,2016: Amarillo Biosciences Receives Approval of Patent Claims - Treatment of Thrombocytopenia Using Orally Administered Interferon

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Amarillo Biosciences Inc - Key Facts 5
Amarillo Biosciences Inc - Key Employees 6
Amarillo Biosciences Inc - Key Employee Biographies 7
Amarillo Biosciences Inc - Major Products and Services 8
Amarillo Biosciences Inc - History 9
Amarillo Biosciences Inc - Locations And Subsidiaries 11
Head Office 11
Section 2 – Company Analysis 12
Amarillo Biosciences Inc - Business Description 12
Amarillo Biosciences Inc - SWOT Analysis 13
SWOT Analysis - Overview 13
Amarillo Biosciences Inc - Strengths 13
Amarillo Biosciences Inc - Weaknesses 14
Amarillo Biosciences Inc - Opportunities 15
Amarillo Biosciences Inc - Threats 16
Amarillo Biosciences Inc - Key Competitors 17
Section 3 – Company Financial Ratios 18
Financial Ratios - Capital Market Ratios 18
Financial Ratios - Annual Ratios 19
Performance Chart 21
Financial Performance 21
Financial Ratios - Interim Ratios 22
Financial Ratios - Ratio Charts 23
Section 4 – Company’s Lifesciences Financial Deals and Alliances 24
Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24
Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 25
Amarillo Biosciences Inc, Recent Deals Summary 26
Section 5 – Company’s Recent Developments 27
Oct 06, 2016: Amarillo Biosciences Receives Approval of Patent Claims - Treatment of Thrombocytopenia Using Orally Administered Interferon 27
Section 6 – Appendix 28
Methodology 28
Ratio Definitions 28
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Amarillo Biosciences Inc, Key Facts 5
Amarillo Biosciences Inc, Key Employees 6
Amarillo Biosciences Inc, Key Employee Biographies 7
Amarillo Biosciences Inc, Major Products and Services 8
Amarillo Biosciences Inc, History 9
Amarillo Biosciences Inc, Key Competitors 17
Amarillo Biosciences Inc, Ratios based on current share price 18
Amarillo Biosciences Inc, Annual Ratios 19
Amarillo Biosciences Inc, Annual Ratios (Cont...1) 20
Amarillo Biosciences Inc, Interim Ratios 22
Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24
Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 25
Amarillo Biosciences Inc, Recent Deals Summary 26
Currency Codes 28
Capital Market Ratios 28
Equity Ratios 29
Profitability Ratios 29
Cost Ratios 30
Liquidity Ratios 30
Leverage Ratios 31
Efficiency Ratios 31
List of Figures
Amarillo Biosciences Inc, Performance Chart (2012 - 2016) 21
Amarillo Biosciences Inc, Ratio Charts 23
Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 24
Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 25
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 

Related Reports